Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 03/22/22
Due: 03/22/23
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 11/13/20
Due: 11/13/21
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 07/19/17
Due: 07/19/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa | NCT04604899 | jCyte, Inc | user2@example.com | None | 2020-12-01 | 2022-03-22 | 2023-03-22 | - | - | 2025-07-14 |
| Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) | NCT06912633 | jCyte, Inc | user2@example.com | None | 2025-06-30 | 2026-09-30 | 2027-09-30 | - | - | 2025-07-14 |
| Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa | NCT03073733 | jCyte, Inc | user2@example.com | None | 2017-03-01 | 2020-11-13 | 2021-11-13 | - | - | 2025-07-14 |
| Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa | NCT02320812 | jCyte, Inc | user2@example.com | None | 2015-06-30 | 2017-07-19 | 2018-07-19 | - | - | 2025-07-14 |